Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Vets identify genetic cause of fatal condition in Thoroughbreds
EFIH is an invariably fatal condition that causes involuntary contraction of muscles and seizures in Thoroughbred foals.
Study of affected foals reveals a mutation in the RAPGEF5 gene.

A genetic cause of equine familial isolated hypoparathyroidism (EFIH) in Thoroughbreds has been identified by researchers at the UC Davis School of Veterinary Medicine.

Researchers say their finding, reported in PloS Genetics, marks the first genetic variant for hypoparathyroidism identified in any domestic animal species. It is also the first widely available genetic test for Thoroughbreds.

“For Thoroughbred owners and breeders, the loss of a foal has tremendous economic and emotional impacts,” says first author Victor Rivas. “It is important to promote safe and strategic breeding habits by actively breeding horses genetically screened not only for EFIH but for other diseases that may impact quality of life.”

EFIH is is an invariably fatal condition that causes involuntary contraction of muscles and seizures in Thoroughbred foals. Foals with the disease typically have low levels of parathyroid - a hormone that controls calcium levels - and often die or are euthanised owing to poor prognosis.

In the study, researchers identified an autosomal recessive mode of inheritance and performed whole-genome sequencing of two affected foals. They found that a mutation in the rap guanine nucleotide exchange factor 5 (RAPGEF5) gene was present in two copies in both foals.

The team further analysed the variant and demonstrated loss-of-function of the RAPGEF5 protein leading to aberrant development. Their study concludes that RAPGEF5 could play a key role in the derivation of the parathyroid gland during development.

“The next steps are to assess the allele frequency in a large population of randomly selected Thoroughbreds,” explained study lead Dr Carrie Finno. “Additionally, we have discussed collaborating with Dr Nathan Slovis at Hagyard Equine Medical Institute in Kentucky to test for the variant in cases of ‘sudden death’ in Thoroughbred foals.”

Become a member or log in to add this story to your CPD history

RCVS Knowledge appoints Veterinary Evidence editor-in-chief

News Story 1
 RCVS Knowledge has welcomed Professor Peter Cockcroft as editor-in-chief for Veterinary Evidence.

A world-renowned expert in evidence-based veterinary medicine, Prof Cockcroft will lead the strategic development and editorial quality of the open-access journal. He was previously in the role from 2017-2020.

Katie Mantell, CEO of RCVS Knowledge, said: "We are excited about the extensive knowledge of evidence-based veterinary medicine and clinical veterinary research that Peter brings, and we look forward to working with him over this next phase of the journal's development." 

Click here for more...
News Shorts
Defra to host bluetongue webinar for vets

The Department for Environment, Food and Rural Affairs (Defra) will be hosting a webinar for veterinary professional on bluetongue on Thursday, 25 April 2024.

Topics covered will include the transmission cycle, pathology and pathogenesis, clinical signs (including signs seen in recent BTV-3 cases in the Netherlands), and control and prevention.

The session, which will take place from 6pm to 7.30pm, is part of Defra's 'Plan, Prevent and Protect' webinar series, which are hosted by policy officials, epidemiologists and veterinary professionals from Defra and the Animal and Plant Health Agency. The bluetongue session will also feature insights from experts from The Pirbright Institute.

Those attending will have the opportunity to ask questions. Places on the webinar can be booked online.